US Animal Biotechnology Market 2024 To 2033

US Animal Biotechnology Market Size, Trends and Insights By Product (Diagnostics Tests, Vaccines and Drugs, Reproductive and Genetic, Feed Additives, Others), By Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others), By End User (Veterinary Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others), and By Region - Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033.

Reports Description

As per the current market research conducted by the CMI Team, the US Animal Biotechnology Market is expected to record a CAGR of 7.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 13,019.9 Million. By 2033, the valuation is anticipated to reach USD 24,138.7 Million.

The US animal biotechnology market is defined in the research study as the development and application of technologies to advance animal health, productivity, and welfare. These include genetic engineering and advanced diagnostics, vaccines, and therapeutics to enhance livestock management and disease prevention.

The market is driven by increasing advancements in precision medicine, AI, & data analytics and rising consumer demands for transparency and sustainability. Zoetis leads the market share, while Elanco follows closely in this segment. Currently, these two companies are doing the most to mitigate the health and environmental consequences of the rising global demand for animal-derived products.

For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=60239